Starting July 1, the Bridge program will serve as the Centers for Medicare & Medicaid Services (CMS) vehicle to provide expanded access to GLP-1 obesity medications.
Women with obesity experience additional barriers to care due to stigma, economic inequality, and limited access to appropriate care. Centering comprehensive solutions to these issues in the national approach to obesity care and policy could help improve outcomes for women across the lifespan.
SWHR is excited to announce it will be back at the United Nations General Assembly (UNGA80) Science Summit in September 2025, in partnership with the ECHAlliance - The Global Health Connector.
On July 1, 2025, the National Hispanic Council on Aging hosted a Capitol Hill briefing about some of the key health care issues impacting Hispanic Americans.
On July 22, 2025, SWHR hosted a congressional briefing providing an overview of the obesity landscape in the United States. During the discussion, a panel of experts shared insights into obesity and women's health.
SWHR attended the Organization for the Study of Sex Differences (OSSD) 2025 Annual Meeting in Albuquerque, New Mexico. SWHR, alongside the Women’s Health Research Cluster, Womenmind at CAMH, and Elsevier, kicked off the annual meeting with a pre-conference symposium.
SWHR is pleased to introduce its first Women’s Health Research Agenda, published in the Journal of Women’s Health this January.
SWHR's latest policy agenda includes insights gained from an interdisciplinary Obesity Policy Working Group of policy professionals, researchers, clinicians, and patient advocates who met in spring 2024.
Midlife represents about 63% of women in the United States, according to data from the U.S. Census Bureau. Yet, health research focused on this critical window for healthy aging interventions in women has been understudied.